The treatment of PTEN-proficient GBM cells (LN18) with ATRA modulated the expression of several biomarkers associated with apoptosis, including the Bax: Bcl-2 ratio, cytosolic release of cytochrome C, and the activation of Caspase-3 [23]. Here, PTEN is linked to glioblastoma.